ArticleMolecular biomedicine2025

Development of a trispecific fusion protein based on angiotensin-converting enzyme 2, glycoprotein 130, and tumor necrosis factor receptor 2 as a promising therapeutic for COVID-19.

Yongfeng Qiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.